|
answer text |
<p>Participating National Health Service trusts continue to report monthly performance
data regardless of testing. During the period of field-testing (from August 2019),
performance against the 18-week standard will not be calculated or published for these
providers or affected clinical commissioning groups (CCGs) to reflect the change in
performance framework under which the commissioner requested services providers are
operating. Data from these providers will still be used to calculate and publish performance
against the 18-week standard at the regional and England level. The reporting arrangements
for trusts following completion of the field-testing is dependent on the outcome of
the testing and final recommendations made as part of the Clinical Review of Access
Standards.</p><p> </p><p>Participating CCGs and providers are still required to follow
2019/20 Planning Guidance for managing improvements to elective care waiting times
which are focused on reducing the size of the waiting list as a means to reducing
patient waiting times. From April 2019, providers and commissioners will be fined
£2,500 for each patient whose wait for treatment is more than 52 weeks. No other sanctions
or penalties are in place.</p><p> </p>
|
|